Related Experiment Videos
Revisiting hereditary hemochromatosis: current concepts and progress.
Andrew W Yen1, Tonya L Fancher, Christopher L Bowlus
1University of California, Davis Medical Center, Department of Internal Medicine, Sacramento, Calif 95817, USA. andrew.yen@ucdmc.ucdavis.edu
The American Journal of Medicine
|May 3, 2006
Summary
Hereditary hemochromatosis, once rare, is now the most common genetic disorder in people of European ancestry. Advances in iron metabolism and genetics have updated diagnosis and management strategies.
Area of Science:
- Genetics
- Internal Medicine
- Epidemiology
Background:
- Hereditary hemochromatosis (HH) was historically considered a rare condition.
- It is now recognized as the most prevalent genetic disorder among European ancestry populations.
- Previous understanding linked HH to "bronze diabetes".
Purpose of the Study:
- To review the pathophysiology, epidemiology, clinical features, diagnostic testing, and management of HH.
- To provide primary care providers with updated information on iron overload disorders.
- To highlight recent advances impacting HH diagnosis and care.
Main Methods:
- Review of recent advances in iron metabolism.
- Analysis of the identified gene responsible for hereditary hemochromatosis.
- Examination of large-scale epidemiologic studies.
- Synthesis of current diagnostic and management approaches.
Main Results:
- Hereditary hemochromatosis is the most common genetic disorder in European ancestry populations.
- Understanding of iron metabolism and HH genetics has significantly advanced.
- Diagnostic strategies for HH and other iron overload conditions have evolved.
Conclusions:
- Primary care providers need updated knowledge on HH.
- Current diagnostic and management protocols reflect recent scientific breakthroughs.
- Hereditary hemochromatosis requires a revised clinical approach.